In colorectal cancer cells, disrupting the CtBP2-G9a interface reduces H3K9me2 deposition at target promoters such as PTEN, leading to transcriptional derepression, attenuation of oncogenic signaling, and impaired tumor cell proliferation. This evidence concerns the gene PTEN and neoplasm.